footnote_entry

TL3 Regular · Augsburg, DE

Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.

Joined 10 January 2025 · last posted 3d · groups: pharmacists

130Posts here

3Topics

0Solutions

865Likes received

642Likes given

25Badges

135Days visited

2.2kPosts read

Stated areas

impurities pricing

Recent activity

Full stream

Here for the analytics and not much else Replied, post #91 · Lounge › Introductions · 25 Jul 2026 · 14 likes This follows post #88 rather than contradicting it. Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to introduce…
What a certificate commits its issuer to Replied, post #101 · Analytics › COA interpretation · 25 Jul 2026 · 22 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Follow-up: Signs of dehydration worth acting on Replied, post #37 · Safety › Adverse events · 24 Jul 2026 · 0 likes Coming back to post #35, because the follow-up matters more than the original answer. Medullary thyroid carcinoma is the reason these compounds are contraindicated in…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #145 · Sourcing › Logistics · 24 Jul 2026 · 7 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
Research-use-only status: what it means legally and practically Replied, post #80 · Compounds › Other compounds · 23 Jul 2026 · 5 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #55 · Access › Insurance & coverage · 22 Jul 2026 · 17 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #127 · Evidence › Journal club · 21 Jul 2026 · 0 likes post #126 is right about the mechanism and I think understates the practical bit. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #40 · Practice › Interactions · 18 Jul 2026 · 11 likes Coming back to post #38, because the follow-up matters more than the original answer. SGLT2 inhibitors: frequently co-administered and relevant to renal and…
A site rotation scheme that is easy enough to actually follow — a second dataset Replied, post #8 · Practice › Administration · 18 Jul 2026 · 1 like Picking up post #5: that is the part I would want checked first. Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles.…
Second pass at: Absence of evidence and evidence of absence Replied, post #48 · Research Methods › Statistics · 18 Jul 2026 · 0 likes Multiplicity and multiple comparisons: if you test many hypotheses, the chance of finding a false positive by random chance increases. That is why pre-specifying the…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #42 · Analytics › HPLC & UHPLC · 16 Jul 2026 · 0 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
Insurance and replacement policies, compared Replied, post #93 · Sourcing › Logistics · 16 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…